Kisqali Femara Co-Pack and Mesalamine Controlled-Release Capsules
Determining the interaction of Kisqali Femara Co-Pack and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack-Mesalamine Delayed Release Tablets
- Kisqali Femara Co-Pack-Mesalamine Long-Acting Capsules (Apriso)
- Kisqali Femara Co-Pack-Mesalamine Long-Acting Capsules (Delzicol)
- Kisqali Femara Co-Pack-Mesalamine Long-Acting Capsules (Pentasa)
- Kisqali Femara Co-Pack-Mesalamine rectal
- Kisqali Femara Co-Pack-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Mesalamine Controlled-Release Capsules-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Mesalamine Controlled-Release Capsules-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Mesalamine Controlled-Release Capsules-Kitabis Pak
- Mesalamine Controlled-Release Capsules-Kitabis Pak inhalation
- Mesalamine Controlled-Release Capsules-Klofensaid II